Aurobindo Pharma Limited — Updates, 12-06-2026: General Updates
12-06-2026 | 06:13 pm
12-06-2026 | 06:13 pm
Aurobindo's subsidiary Eugia Pharma's Unit-III received a US FDA "Official Action Indicated" (OAI) classification after an inspection with 11 observations. The company confirms no impact on its financials or operations.
No comments yet. Be the first to comment!
